The ISCT Global Regulatory Perspectives (GRP) workshop represents the diverse activities and partnerships between international regulatory bodies, industry, clinicians and academia.
The GRP Workshop is an annual one-day program. Unique to this workshop is the attendance of regulators from North America, Europe, Asia, South & Central America and Australia & New Zealand. It is a highly interactive program including various hypothetical case studies throughout.
Karen Nichols, Esq.
Yong Fan, MD
A2Z Reg Solutions
Christopher Bravery, PhD
Consulting on Advanced Biologicals
Scott Burger, MD
Advanced Cell & Gene Therapy
Dominic Wall, PhD, FFSc(RCPA)
Cell Therapies Pty Ltd, Peter MacCallum Cancer Centre
Srinivasan Kellathur, PhD
Advanced Therapy Products Unit, Health Sciences Authority
Janet Macpherson, PhD
GE Life Sciences
Organized by the ISCT MSC Scientific Committee, the Society’s scientific thought leadership on MSCs, this Pre-Conference Day Track provides the unique opportunity to bring together preeminent leaders from around the world to present their cutting-edge research and discuss key challenges related to discovery, development and clinical deployment of mesenchymal stromal cells.
Jacques Galipeau, MD
University of Wisconsin-Madison
Mauro Krampera, MD
University of Verona
Luc Sensebe, MD, PhD
ISCT MSC Committee
Join the journey from ‘Needle to Needle’ as the 2020 Cell Processing Track features a carefully curated program offering a unique look into the production of cell-based products, with a focus on novel processing techniques including gene editing, cell activation and expansion and characterization by flow cytometry. This practical workshop will provide delegates an opportunity to dig into the details of what it takes to bring a product from bench to bedside.
Ruud Hulspas, PhD
Cellular Technologies Bioconsulting, LLC
Mara Neal, SH(ASCP)MT, MS, MBA
Vicki Antonenas, MSc
Paul Wallace, PhD
Roswell Park Comprehensive Cancer Center
The inaugural investigators to investors (i to i) pre-conference track will bring together cell and gene therapy investors for a half-day educational event providing unparalleled access to cell and gene therapy key opinion leaders. The track will commence with a state of the industry overview and panel discussion covering topics crucial to investor due diligence, followed by meet the experts style session where attendees will have the opportunity to meet with the experts of their choosing for roundtable discussions.
More information on featured key opinion leaders is coming soon.
Patrick Rivers, MBA
Formerly the ISCT-CBA Cord Blood Series, the newly branded ISCT-Cord Blood Connect is brought to you by ISCT and the Cord Blood Association (CBA), now in partnership with the World Marrow Donor Association (WMDA). For the sixth consecutive year, join the world’s leading cord blood experts at the ISCT Annual Meeting to learn about the latest advancements in cord blood biology and transplantation, and its application in the translation of novel cell therapies.
Elizabeth J. Shpall, MD
MD Anderson Cancer Center
Joanne Kurtzberg, MD
Carolina’s Cord Blood Bank Duke University Medical Center
Ngaire Elwood, PhD
BMDI Cord Blood Bank and Murdoch Children’s Research Institute